Development and validation of predictive model based on deep learning method for classification of dyslipidemia in Chinese medicine

[1]  G. Thanassoulis,et al.  Updated guidelines for the management of dyslipidemia and the prevention of cardiovascular disease in adults by pharmacists , 2023, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

[2]  Junjie Zhu,et al.  Obesity and Dyslipidemia in Chinese Adults: A Cross-Sectional Study in Shanghai, China , 2022, Nutrients.

[3]  Hager Saleh,et al.  Predicting Breast Cancer Based on Optimized Deep Learning Approach , 2022, Computational intelligence and neuroscience.

[4]  Jing Li,et al.  Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China , 2021, JAMA network open.

[5]  Jing Chen,et al.  Study on the Effect of Macrophages on Vascular Endothelium in Mice With Different TCM Syndromes of Dyslipidemia and its Biological Basis Based on RNA-Seq Technology , 2021, Frontiers in Pharmacology.

[6]  J. Aronson,et al.  Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses , 2021, BMJ.

[7]  Florent Meyniel,et al.  Gated recurrence enables simple and accurate sequence prediction in stochastic, changing, and structured environments , 2021, bioRxiv.

[8]  Incheol Kim,et al.  Tracklet Pair Proposal and Context Reasoning for Video Scene Graph Generation , 2021, Sensors.

[9]  G. Norata,et al.  Global epidemiology of dyslipidaemias , 2021, Nature Reviews Cardiology.

[10]  M. Banach,et al.  Effects of statins on mitochondrial pathways , 2021, Journal of Cachexia, Sarcopenia and Muscle.

[11]  Usha Ruby Dr.A,et al.  Binary cross entropy with deep learning technique for Image classification , 2020 .

[12]  Li Yang,et al.  Study of cardiovascular disease prediction model based on random forest in eastern China , 2020, Scientific Reports.

[13]  Li Yang,et al.  Study of cardiovascular disease prediction model based on random forest in eastern China , 2020, Scientific Reports.

[14]  Bin Huang,et al.  Opening the black box of neural networks: methods for interpreting neural network models in clinical applications. , 2018, Annals of translational medicine.

[15]  Abien Fred Agarap.  Deep Learning using Rectified Linear Units (ReLU) , 2018, ArXiv.

[16]  D. Matthews,et al.  Prevalence, patterns, and associations of dyslipidemia among Sri Lankan adults-Sri Lanka Diabetes and Cardiovascular Study in 2005-2006. , 2018, Journal of clinical lipidology.

[17]  Po-Yin Chang,et al.  Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study , 2017, Diabetes Care.

[18]  Jane C. Deng,et al.  Prediction of Clinical Deterioration in Hospitalized Adult Patients with Hematologic Malignancies Using a Neural Network Model , 2016, PloS one.

[19]  Anna Goldenberg,et al.  TensorFlow: Biology's Gateway to Deep Learning? , 2016, Cell systems.

[20]  Jimmy Ba,et al.  Adam: A Method for Stochastic Optimization , 2014, ICLR.

[21]  Ming Guo,et al.  Chinese Herbal Medicine on Dyslipidemia: Progress and Perspective , 2014, Evidence-based complementary and alternative medicine : eCAM.

[22]  Francesco Pappalardo,et al.  Mathematical modeling of biological systems , 2013, Briefings Bioinform..

[23]  A. Tamakoshi,et al.  Relation Between Serum Total Cholesterol Level and Cardiovascular Disease Stratified by Sex and Age Group: A Pooled Analysis of 65 594 Individuals From 10 Cohort Studies in Japan , 2012, Journal of the American Heart Association.

[24]  J. Gallacher,et al.  Lipid-related markers and cardiovascular disease prediction. , 2012, JAMA.

[25]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[26]  Tom Fawcett,et al.  An introduction to ROC analysis , 2006, Pattern Recognit. Lett..

[27]  Paulo J. G. Lisboa,et al.  The Use of Artificial Neural Networks in Decision Support in Cancer: a Systematic Review , 2005 .

[28]  Bogusław Stefaniak,et al.  [Algorithms of artificial neural networks--practical application in medical science]. , 2005, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[29]  S. Nicholls,et al.  The emerging role of lipoproteins in atherogenesis: beyond LDL cholesterol. , 2004, Seminars in vascular medicine.

[30]  L. Breiman.  Random Forests , 2001, Encyclopedia of Machine Learning and Data Mining.

[31]  W Penny,et al.  Neural Networks in Clinical Medicine , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.

[32]  Claudio Moraga,et al.  The Influence of the Sigmoid Function Parameters on the Speed of Backpropagation Learning , 1995, IWANN.

[33]  Kurt Hornik,et al.  Approximation capabilities of multilayer feedforward networks , 1991, Neural Networks.

[34]  D. Levy,et al.  Cholesterol and mortality. 30 years of follow-up from the Framingham study. , 1987, JAMA.

[35]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[36]  Shuangfeng Li,et al.  Research Progress of Traditional Chinese Medicine in Treatment of Hyperlipidemia , 2013 .

[37]  Mark D. Huffman,et al.  Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[38]  Filippo Castiglione,et al.  Mathematical and Computational Models in Tumor Immunology , 2012 .

[39]  Thomas Lengauer,et al.  Permutation importance: a corrected feature importance measure , 2010, Bioinform..

[40]  T. Hastie,et al.  Statistical Models in S , 1991 .